Home » DNA Toxicity Studies Should Weigh Sum of Test Results, EMA Says
DNA Toxicity Studies Should Weigh Sum of Test Results, EMA Says
January 10, 2012
Drugmakers testing drugs’ genotoxicity should consider the sum of the test results, as well as the intrinsic limitations of in vitro and in vivo tests, according to a revised European Medicines Agency (EMA) guideline.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor